Abstract
Restrictive patenting and licensing for cell-free fetal DNA testing has serious consequences for technology advances and benefits to public health.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
DNA / blood*
-
Female
-
Fetus
-
Humans
-
Pregnancy
-
Prenatal Diagnosis / economics
-
Prenatal Diagnosis / methods*